Fritextsökning
Innehållstyper
-
Novo Nordisk to invest billions in Danish manufacturing facilities
Danish pharmaceutical giant Novo Nordisk is investing DKK 42 billion, equivalent to around SEK 65 billion/EUR 5.6 billion, in its manufacturing facilities in Ka...
-
FDA-beslut: AZ:s nasala influensavaccin får tas av patienten själv
Astra Zenecas nasala influensavaccin Flumist har godkänts för självadministrering i USA. Det är därmed det första influensavaccinet i USA som inte behöver ges av en vårdgivare.
-
ZEISS Metrology Expert Tips
New video series provides valuable expert knowledge.
-
Nytt läkemedel mot schizofreni godkänt i USA
För första gången på flera decennier har en ny typ av läkemedel mot schizofreni godkänts av den amerikanska läkemedelsmyndigheten FDA.
-
Join us at SLAS Barcelona
Festo LifeTech is exhibiting at the SLAS in Barcelona.
-
GSK pays 2.2 billion dollars to settle Zantac lawsuits
British drugmaker Glaxo Smith Kline, GSK, has struck a 2.2 billion dollar settlement, thereby resolving a vast majority of the liability cases pending against t...
-
Study: Popular diabetes drug may be effective against liver disease
After its success in diabetes and weight loss, a new potential therapeutic area has been identified for Ozempic and other GLP1 analogues. A new study links the ...
-
Biosimilars bring price pressure, but are they sufficiently used?
When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...
-
Rising interest in CRISPR treatments
Treatments using CRISPR technology are emerging as one of the hottest medical trends in the United States – and the FDA is doing its best to promote the development.
-
Donanemab godkänns i Storbritannien – men anses för dyrt för skattebetalarna
Eli Lillys alzheimerläkemedel donanemab godkänns i Storbritannien – men lär ändå inte bli tillgängligt för vanliga patienter. Orsaken är att behandlingen bedöms...
-
Settlement of cancer allegations against blockbuster drug
French pharmaceutical company Sanofi has reached a principal agreement in the US on around 4,000 of the cases in which its now withdrawn blockbuster heartburn d...
-
Stor kongress om framtidsutsikter igång i Lund
Vad sker i framtiden inom svensk och dansk life science? Det diskuteras i dag vid eventet The Future of Swedish and Danish Life Science i Lund.
-
The physician at the tech giant: “Observations in the emergency room made my mind up”
When Nasim Farrokhnia was in third grade at school in Tehran, the capital of Iran, her father gave her a book about Marie Curie, which soon became her favourite...
-
ZEISS Quality Innovation Days: April 15 – 19, 2024
Be there when industry experts give exciting insights into different applications and trends in 90 minutes on various theme days.
-
The International Vaccine Institute’s office in Sweden is expanding
The International Vaccine Institute’s Stockholm office has been open for over a year. During the past year, training programmes and projects have been launched,...
-
Just four weeks to a concept for an emergency ventilator
The lockdown in spring 2020 meant that the majority of Festo employees had to join the ranks of those working from home. Yet within the space of just four weeks...
-
Study: Cancer vaccine prolongs survival in difficult-to-treat tumour disease
According to a new study, a combination of a cancer vaccine from Norwegian company Ultimovacs and two immunotherapies significantly prolonged survival in cases ...
-
Giulia Gaudenzi: Innovation for good
"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively ...
-
“Unfortunately, we are not strong when it comes to conducting clinical trials”
The number of company-initiated clinical trials conducted in Sweden has been declining in recent years. In mid-March, a government inquiry was presented that ai...
-
Marie Gårdmark: ”The situation is not satisfactory”
”The legislative tool-box is limited, but carrots in the form of longer exclusivity has already proven successful, this has for example increased registration o...
-
EU bokar 40 miljoner doser fågelinfluensavaccin
EU säkrar 40 miljoner doser vaccin mot fågelinfluensa – redan innan smittan nått Europa.
-
Här är de mest attraktiva arbetsplatserna när naturvetare får välja
Både läkemedelsföretag och universitet är några av de mest attraktiva arbetsgivarna inom life science-sektorn när naturvetare får välja. Det visar en ny undersö...
-
Improve your secondary battery manufacturing
SMC provides a large portfolio of products specially designed for secondary battery industry.
-
A new special edition and a new event in Copenhagen – This is happening at Life Science Sweden 2024
The new year brings new features for the readers of Life Science Sweden.
BREAKING